Study of the impact of liver transplantation on the outcome of intestinal grafts in children

Transplantation

Volumn 81, Issue 7, 2006, Pages 992-997

  Jugie, Myriam ^a,b   Canioni, Danielle ^b   Le Bihan, Christine ^b   Sarnacki, Sabine ^b   Revillon, Yann ^b   Jan, Dominique ^b   Lacaille, Florence ^b   Cerf Bensussan, Nadine ^b   Goulet, Olivier ^b   Brousse, Nicole ^b   Damotte, Diane ^c,d  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d INSERM   (France)

Author keywords

Intestinal transplantation; Liver; Pediatric; Tolerance

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; INTESTINE TRANSPLANTATION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; LIVER TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 33646348170     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000195899.32734.83     Document Type: Article

References (52)

1. Todo S, Tzakis A, Reyes J, et al. Clinical small bowel or small bowel plus liver transplantation under FK506. Transplant Proc 1991; 23: 3093.
2. Jan D, Michel JL, Goulet O, et al. Up-to-date evolution of small bowel transplantation in children with intestinal failure. J Pediatr Surg 1999; 34: 841.
3. Goulet O. Intestinal transplantation. Curr Opin Clin Nutr Metab Care 1999; 2: 315.
4. Grant D, Abu-Elmagd K, Reyes I, et al. On behalf of the Intestine Transplant Registry. 2003 Report of the Intestine Transplant Registry: A New Era Has Dawned. Ann Surg 2005; 241: 607.
5. Goulet O, Brousse N, Revillon Y, Ricour C. Pathology of human intestinal transplantation. In: Grant D, ed. Small bowel transplantation. Wood RFM ed. London: Edward Arnold, 1993: 112.
6. Goulet O, Ruemmele F, Lacaille F, Colomb V. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004; 38: 250.
7. Sarnacki S, Cerf-Bensussan N. Immunologic aspects of small bowel transplantation. Curr Opin Organ Transplantation 1999; 4: 343.
8. Qian S, Demetris AJ, Murase N, et al. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
9. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472.
10. Kamada N, Davies HS, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981; 27: 840.
11. Meyer D, Baumgardt S, Loeffeler S, et al. Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction. Transplantation 1998; 66: 1530.
12. Sarnacki S, Nakai H, Calise D, et al. Decreased expression of the interleukin 2 receptor on CD8 recipient lymphocytes in intestinal grafts rendered tolerant by liver transplantation in rats. Gut 1998; 43: 849.
13. Sarnacki S, Revillon Y, Cerf-Bensussan N, et al. Long term small bowel graft survival induced by spontaneously tolerated liver allograft in inbred rat strains. Transplantation 1992; 54: 383.
14. Zhong R, He G, Sakai Y, et al. Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection. Transplantation 1991; 52: 550.
15. Gruessner RW, Nakhleh RE, Benedetti E, et al. Combined liver-total bowel transplantation has no immunologic advantage over total bowel transplantation alone. A prospective study in a porcine model. Arch Surg 1997; 132: 1077.
16. Goulet O, Michel JL, Jobert A, et al. Small bowel transplantation alone or with the liver in children: changes by using FK506. Transplant Proc 1998; 30: 1569.
17. Ishii T, Mazariegos GV, Bueno J, et al. Exfoliative rejection after intestinal transplantation in children. Pediatr Transplantation 2003; 7: 185.
18. White FV, Reyes I, Jaffe R, Yunis EG. Pathology of intestinal transplantation in children. Am J Surg Pathol 1995; 19: 687.
19. Langnas AN, Shaw BW, Antonson DL, et al. Preliminary experience with intestinal transplantation in infants and children. Pediatrics 1996; 97: 443.
20. Grant D. Intestinal transplantation: 1997 report of the international registry. Transplantation 1999; 67: 1061.
21. Misiakos EP, Weppler D, Bakonyi A, et al. Clinical outcome of intestinal transplantation at the University of Miami. Transplant Proc 1999; 31: 569.
22. Opelz G, Margreiter R, Dölher B. Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation 2002; 74: 1390.
23. Katznelson S, Cecka JM. The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation 1996; 61: 1403.
24. Olver S, Goto S, Chiba S, et al. Persistence of donor-reactive CD4+ T cells in liver and spleen of rats tolerant to a liver allograft. Transplantation 1998; 66: 132.
25. Wang C, Sun J, Sheil AGR, et al. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001; 72: 44.
26. Hancock WH. Molecular basis of chronic rejection. Curr Opin Organ Transplant 1999; 4: 3.
27. Soares MP, Lin Y, Sato K, et al. Pathogenesis of and potential therapies for delayed xenograft rejection. Curr Opin Organ Transplant 1999; 4: 80.
28. Takahashi Y, Ganster RW, Gambotto A, et al. Role of NFκB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1175.
29. Bradham CA, Schemmer P, Stachlewitz RF, et al. Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg 1999; 5: 282.
30. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355.
31. Wang CY, Mayo MW, Baldwin AS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996; 274: 784.
32. Goulet O, Auber F, Fourcade L, et al. Intestinal transplantation including the colon in children. Transplant Proc 2002; 34: 1885.
33. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996; 110: 1820.
34. Goulet O. Proceedings. VIII International Small Bowel Transplantation Symposium Miami Bal Harbour, Florida, USA. September 10-13, 2003.
35. Davies HFFS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524.
36. Zazava N, Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T Lymphocytes. Nat Med 1996; 2: 1005.
37. Graeb C, Scherer MN, Knechtle SJ, Geissler EK. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC Class I molecules. Hum Immunol 1998; 59: 415.
38. Van Parijs L, Abbas AK. Abstract Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998; 280: 243.
39. Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts. J. Immunol 1997; 158: 4654.
40. Limmer A, Ohl J, Kurts C, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000; 6: 1348.
41. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411.
42. Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut 2003; 52: 307.
43. Williamson E, Bilsborough JM, Viney JL. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. J Immunol 2002; 169: 3606.
44. Karim M, Bushell AR, Wood KJ. Regulatory T cells in transplantation. Curr Opin Immunol 2002; 14: 584.
45. Vosters O, Neve J, De Wit D, et al. Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory T cells. Transplantation 2003; 75: 383.
46. Lagaraine C, Lebranchu Y. Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation 2003; 75: 37S.
47. Chen LW, Egan L, Li ZW, et al. The two faces of IKK and NF-KB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003; 9: 575.
48. Egan LJ, de Lecea A, Lehrman ED,. Nuclear factor-kappa B activation promotes restitution of wounded intestinal epithelial monolayers. Am J Physiol Cell Physiol 2003; 285: C1028.
49. Egan LJ, Eckmann L, Greten FR, et al. IkappaB-kinasebeta-dependent NF-kappaB activation provides radio-protection to the intestinal epithelium. Proc Natl Acad Sci USA 2004; 101: 2452.
50. Skoberne M, Beignon AS, Larsson M, Bhardwaj N. Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol 2005; 289: 259.
51. Lee RG, Tsamandas AC, Abu-Elmagd K, et al. Histologic spectrum of acute cellular rejection in human intestinal allografts. Transplant Proc 1996; 5: 2767.
52. Kitanaka C, Namiki T, Noguchi K, et al. Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation and apoptosis. Oncogene 1997; 15: 1763.